FIELD: chemistry.
SUBSTANCE: invention concerns new tartrate salts of (1R,2R,3S,5S)-2-methoxymethyl-3-(3,4-difluorophenyl)-8-azabicyclo[3.2.1]octane, such as L-tartrate monohydrates and anhydrates.
EFFECT: application as inhibitors of monoamine neurotransmitter reuptake.
8 cl, 8 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED TROPANIC DERIVATIVES AS NEUROMEDIATOR REVERSE CAPTURE INHIBITORS | 1996 |
|
RU2162469C2 |
| 2,3-TRANS-DISUBSTITUTED TROPAN DERIVATIVE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2167876C2 |
| SUBSTITUTED PIPERIDINE COMPOUNDS AND USE THEREOF | 2021 |
|
RU2840772C1 |
| PHARMACEUTICAL COMPOUNDS | 2019 |
|
RU2821941C2 |
| DERIVATIVES OF 7-PHENOXY-N-(3-AZABICYCLO[3.2.1]OCTAN-8-YL)-6,7-DIHYDRO-5H-PYRROLO[1,2-b][1,2,4]TRIAZOLE-2-AMINE AND RELATED COMPOUNDS AS GAMMA-SECRETASE MODULATORS FOR TREATING ALZHEIMER'S DISEASE | 2019 |
|
RU2841048C2 |
| DERIVATIVES OF 8-AZABICYCLO[3,2,1]OCT-2-ENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DRUG PREPARING, METHODS OF INHIBITION OF REUPTAKE OF MONOAMINE NEUROMEDIATING AGENT, ESPECIALLY, SEROTONIN | 1996 |
|
RU2157372C2 |
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
| OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M | 2019 |
|
RU2817018C2 |
| NEW 8-AZA-BICYCLO[3,2,1]OCTANE DERIVATIVES APPLIED AS MONOAMINE NEUROTRNSMITTER RECAPTURE INHIBITORS | 2004 |
|
RU2344136C2 |
| 2-AZA-BICYCLO[3,3,0]OCTANE DERIVATIVES | 2008 |
|
RU2478099C2 |
